Minocycline for Bipolar Depression

Summary

Minocycline for Bipolar Depression is a clinical trial^[1].

Key Facts

• Minocycline for Bipolar Depression is in the country of United States^[2].
• Minocycline for Bipolar Depression's instance of is recorded as clinical trial^[3].
• Minocycline for Bipolar Depression's start time is recorded as +2011-05-31T00:00:00Z^[4].
• Minocycline for Bipolar Depression's end time is recorded as +2013-08-31T00:00:00Z^[5].
• Minocycline for Bipolar Depression's sponsor is recorded as Icahn School of Medicine at Mount Sinai^[6].
• Minocycline for Bipolar Depression's main subject is recorded as major depressive disorder^[7].
• Minocycline for Bipolar Depression's main subject is recorded as bipolar disorder^[8].
• Minocycline for Bipolar Depression's number of participants is recorded as {'unit': '1', 'amount': '+20'}^[9].
• Minocycline for Bipolar Depression's title is recorded as Minocycline for Bipolar Disorder^[10].
• Minocycline for Bipolar Depression's minimum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+18'}^[11].
• Minocycline for Bipolar Depression's ClinicalTrials.gov ID is recorded as NCT01514422^[12].
• Minocycline for Bipolar Depression's maximum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+68'}^[13].
• Minocycline for Bipolar Depression's research intervention is recorded as minocycline^[14].
• Minocycline for Bipolar Depression's clinical trial phase is recorded as phase IV clinical trial^[15].
• Minocycline for Bipolar Depression's research site is recorded as Icahn School of Medicine at Mount Sinai^[16].
• Minocycline for Bipolar Depression's research subject recruitment status is recorded as completed^[17].
• Minocycline for Bipolar Depression's study type is recorded as interventional study^[18].